左捆支部区域节奏为心房阻塞和轻度到中度降低左心室缩功能
Hiroyuki Kato1, Toshiaki Sato2, Kenji Shimeno3
1Department of Cardiology, Japan Community Healthcare Organization Chukyo Hospital, Nagoya, Japan.
Journal of cardiovascular electrophysiology
|October 17, 2024
概括
左捆支部区域节奏 (LBBAP) 改善了心阻塞和减少喷射分数的患者的心脏功能. 这种节奏方法为双心室节奏提供了一个有希望的替代方案,可以增强心脏功能,而不会导致致命的心律失常.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏节拍是因为心脏节拍.
背景情况:
- 在心房阻塞和轻度到中度减少的左心室喷射率 (LVEF) 的患者中,左束枝区域节奏 (LBBAP) 的有效性尚未完全理解.
- 这项研究调查了LBBAP对LVEF≤50%需要心室节奏的患者的影响.
研究的目的:
- 评估LBBAP在心房阻塞和减少LVEF的患者的临床疗效和心声学改善.
- 评估LBBAP的安全性,特别是致命心室节律失常的发生.
主要方法:
- 有37名心房阻塞和LVEF (36-50%) 的患者接受LBBAP.
- 临床结果和心声学参数在一年后进行评估,随访时间中位数为36个月.
- 分析了LVEF正常化的预测因素.
主要成果:
- LBBAP成功地将LVEF从42.6%提高到52.1% (p<.001),其中64.5%的LVEF达到正常化 (>50%).
- 在随访期间,89%的患者没有复合终点 (死亡,致命的心室节律失常,心力衰竭住院治疗).
- 没有致命的心室心律不整发生;非缺血性心肌病和先前存在的捆绑分支阻塞预测了LVEF正常化.
结论:
- 在心房阻塞和减少LVEF的患者中,LBBAP显著改善心脏缩功能,而不会诱导致命的心室失常.
- 对于这种患者群体来说,LBBAP为双心脏节奏提供了一个可行的替代方案.
更多相关视频
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
1.6K
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
429
相关概念视频
01:18Dysrhythmias IV: Characteristics of Bradyarrhythmias
3
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
3
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
01:22Mitral Stenosis I: Introduction
2
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
01:25Mitral Regurgitation III: Medical Management
4
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
4
01:20Mitral Regurgitation I: Introduction
4
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
4
01:22Mitral Valve Prolapse II: Assessment and Management
3
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
3